The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?

Seren Pehlivanoğlu,1 Nur Acar,2 Sinan Albayrak,1 Muharrem Karakaya,1 Ali Ofluoğlu1 1Department of Ophthalmology, School of Medicine, Yeni Yüzyıl University, Istanbul, Turkey; 2Department of Ophthalmology, School of Medicine, Acibadem University, Istanbul, Turkey Background: Our purpose wa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pehlivanoğlu S, Acar N, Albayrak S, Karakaya M, Ofluoğlu A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/b32f521f6487423d998832a35e979bd0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b32f521f6487423d998832a35e979bd0
record_format dspace
spelling oai:doaj.org-article:b32f521f6487423d998832a35e979bd02021-12-02T05:33:42ZThe assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?1177-5483https://doaj.org/article/b32f521f6487423d998832a35e979bd02018-06-01T00:00:00Zhttps://www.dovepress.com/the-assessment-of-autofluorescence-of-the-crystalline-lens-in-diabetic-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Seren Pehlivanoğlu,1 Nur Acar,2 Sinan Albayrak,1 Muharrem Karakaya,1 Ali Ofluoğlu1 1Department of Ophthalmology, School of Medicine, Yeni Yüzyıl University, Istanbul, Turkey; 2Department of Ophthalmology, School of Medicine, Acibadem University, Istanbul, Turkey Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the severity of diabetic retinopathy in diabetic patients. Patients and methods: In this cross-sectional, comparative study, lens AF was measured with scanning confocal lens fluorescence biomicroscope in diabetic and healthy groups. Full ophthalmological examination was performed. Blood tests of fasting plasma glucose, and glycosylated hemoglobin were also analyzed. The correlation between lens AF results and blood tests was evaluated in both groups. The cutoff value for the diagnosis of DM using lens AF was investigated. Results: The study included 191 subjects with a mean age of 52.09±6.75 years. One hundred and seven (56.0%) subjects were female, and 84 (44.0%) were male. Eighty-two (42.9%) patients had type II DM, and 109 (57.1%) subjects self-reported as normal. The fluorescence ratio (FR) values ranged from 0.09 to 0.46 (0.23±0.06) in the total group. Mean FR measurements of diabetic subjects were significantly higher (0.27±0.06) than those without DM (0.20±0.05), (p=0.001). A statistically significant correlation was found between glycosylated hemoglobin, fasting plasma glucose, and FR. The cutoff point for the FR according to the presence of DM was found to be 0.24 and above (p=0.001), with a sensitivity of 71.95% and a specificity of 80.73%. Conclusion: Measuring AF of human lens as an indirect evidence of increased advanced glycaton end products may helpful in detecting impaired glucose metabolism. Our results show highly significant correlation between possibility of DM and FR. Keywords: lens autofluorescence, diabetes, diabetic retinopathy, HgA1c, fasting plasma glucose, screeningPehlivanoğlu SAcar NAlbayrak SKarakaya MOfluoğlu ADove Medical PressarticleLens autofluorescencediabetesdiabetic retinopathyHgA1cfasting plasma glucosescreening.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 1163-1170 (2018)
institution DOAJ
collection DOAJ
language EN
topic Lens autofluorescence
diabetes
diabetic retinopathy
HgA1c
fasting plasma glucose
screening.
Ophthalmology
RE1-994
spellingShingle Lens autofluorescence
diabetes
diabetic retinopathy
HgA1c
fasting plasma glucose
screening.
Ophthalmology
RE1-994
Pehlivanoğlu S
Acar N
Albayrak S
Karakaya M
Ofluoğlu A
The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
description Seren Pehlivanoğlu,1 Nur Acar,2 Sinan Albayrak,1 Muharrem Karakaya,1 Ali Ofluoğlu1 1Department of Ophthalmology, School of Medicine, Yeni Yüzyıl University, Istanbul, Turkey; 2Department of Ophthalmology, School of Medicine, Acibadem University, Istanbul, Turkey Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the severity of diabetic retinopathy in diabetic patients. Patients and methods: In this cross-sectional, comparative study, lens AF was measured with scanning confocal lens fluorescence biomicroscope in diabetic and healthy groups. Full ophthalmological examination was performed. Blood tests of fasting plasma glucose, and glycosylated hemoglobin were also analyzed. The correlation between lens AF results and blood tests was evaluated in both groups. The cutoff value for the diagnosis of DM using lens AF was investigated. Results: The study included 191 subjects with a mean age of 52.09±6.75 years. One hundred and seven (56.0%) subjects were female, and 84 (44.0%) were male. Eighty-two (42.9%) patients had type II DM, and 109 (57.1%) subjects self-reported as normal. The fluorescence ratio (FR) values ranged from 0.09 to 0.46 (0.23±0.06) in the total group. Mean FR measurements of diabetic subjects were significantly higher (0.27±0.06) than those without DM (0.20±0.05), (p=0.001). A statistically significant correlation was found between glycosylated hemoglobin, fasting plasma glucose, and FR. The cutoff point for the FR according to the presence of DM was found to be 0.24 and above (p=0.001), with a sensitivity of 71.95% and a specificity of 80.73%. Conclusion: Measuring AF of human lens as an indirect evidence of increased advanced glycaton end products may helpful in detecting impaired glucose metabolism. Our results show highly significant correlation between possibility of DM and FR. Keywords: lens autofluorescence, diabetes, diabetic retinopathy, HgA1c, fasting plasma glucose, screening
format article
author Pehlivanoğlu S
Acar N
Albayrak S
Karakaya M
Ofluoğlu A
author_facet Pehlivanoğlu S
Acar N
Albayrak S
Karakaya M
Ofluoğlu A
author_sort Pehlivanoğlu S
title The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
title_short The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
title_full The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
title_fullStr The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
title_full_unstemmed The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
title_sort assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/b32f521f6487423d998832a35e979bd0
work_keys_str_mv AT pehlivanoglus theassessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT acarn theassessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT albayraks theassessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT karakayam theassessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT ofluoglua theassessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT pehlivanoglus assessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT acarn assessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT albayraks assessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT karakayam assessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
AT ofluoglua assessmentofautofluorescenceofthecrystallinelensindiabeticpatientsandhealthycontrolscanitbeusedasascreeningtest
_version_ 1718400370133172224